Pustular psoriasis is an extremely rare but severe form of psoriasis characterized by the formation of pustules that may be associated with systemic symptoms. It is an inflammatory skin disease that manifests itself as acute pustular rashes, usually against the background of erythema. Pustular psoriasis can manifest itself both in a localized form and in a generalized form, which increases the risk of developing serious complications, including infectious processes. Clinical manifestations of the disease include itching, burning, and soreness of the affected areas. Pustular psoriasis requires a careful approach to diagnosis and treatment, as it is prone to relapses and can significantly worsen the quality of life of patients.
History of the disease and interesting historical facts
Pustular psoriasis has been known for a long time, but its exact history and understanding of the disease have changed over the centuries. In the early 20th century, pustular psoriasis was first described as a distinct condition from classic psoriasis. Many physicians and dermatologists sought to determine the pathogenesis and causes of the disease in their research. In the 1960s, Canadian-born Dr. John Hirsch coined the terms “pustular psoriasis” and “regal psoriasis,” which temporarily sparked interest in the condition. Interestingly, ancient medical texts mention symptoms similar to pustular psoriasis, but they were often attributed to other dermatoses.
Epidemiology
The epidemiology of pustular psoriasis is very limited, as it occurs in less than 11% of all patients with psoriasis. According to various data, its prevalence ranges from 0.11% to 31% of all forms of psoriasis. There is evidence that pustular psoriasis is more often observed in adults aged 20 to 60 years, with equal frequency in both men and women. However, the disease can occur at any age, including childhood, which requires careful monitoring of younger populations.
Genetic predisposition to this disease
Genetic factors play a significant role in the development of pustular psoriasis. Research suggests that patients suffering from the disease may have mutations in a number of genes associated with the immune response, such as IL36RN and CARD14. Mutations in the IL36RN gene, which encodes an antimicrobial peptide, may lead to abnormal skin inflammation, which explains the presence of pustules and erythema. Other genes associated with psoriasis have also been identified that may increase the risk of developing the disease. However, the exact mechanisms of inheritance remain unclear and require further research.
Risk factors for the development of this disease
There are a number of risk factors that contribute to the development of pustular psoriasis. These include:
- Infections, especially streptococcal or fungal
- Physical factors such as skin trauma or sunburn
- Chemical factors, including the use of certain medications such as beta blockers and lithium
- Stress and emotional experiences
- Smoking and alcohol abuse
- Overweight and metabolic disorders
These factors may increase the clinical manifestations of the disease or lead to its exacerbation. The study of these factors is of interest for the development of methods for the prevention and treatment of pustular psoriasis.
Diagnosis of this disease
Diagnosis of pustular psoriasis is based on clinical examination and anamnesis. The main symptoms include:
- Formation of pustules filled with serous or purulent fluid
- Severe itching and burning
- Erythema around pustules
- Systemic manifestations such as fever and malaise
Laboratory tests may include tests for infections, such as bacteria or fungi. Radiologic tests are not usually needed but may be useful to rule out other conditions. Other diagnostic methods may include skin biopsy to determine the cellular composition of the lesions. Differential diagnosis is important with other forms of psoriasis, such as plaque psoriasis, and dermatoses, such as dermatitis.
Treatment
Treatment of pustular psoriasis should be comprehensive and individually tailored. It may include:
- General treatment using systemic drugs such as corticosteroids or immunosuppressants
- Pharmacological treatment including topical steroids and retinoids
- Surgical treatment may be indicated in rare cases when conservative therapy is ineffective.
- Phototherapy and laser treatment
- New biological drugs aimed at modulating the immune response
Each method requires careful selection and supervision by a physician to minimize the risk of side effects and improve the patient's quality of life.
List of medications used to treat this disease
The list of medications that can be used to treat pustular psoriasis includes:
- Methotrexate
- Cyclosporine
- Augmentina
- Topical corticosteroids (eg, betamethasone, triamcinolone)
- Biologics (eg, adalimumab, ustekinumab)
- Retinoids (eg, acetretin)
The efficacy and tolerability of therapeutic agents should be assessed at each stage of treatment.
Disease monitoring
Monitoring of a patient with pustular psoriasis includes regular clinical examinations, blood tests, and assessment of response to treatment. Follow-up should be based on new skin findings, side effects, and systemic manifestations. Prognosis may vary; some patients experience long-term remission, while others experience frequent relapses. Complications may include infections, dehydration, and toxic epidermal necrolysis.
Age-related features of the disease
Pustular psoriasis may present in different age groups with unique characteristics. In children, the disease may be more severe, with a high risk of developing systemic symptoms. In adults, the disease may be cyclical, with periods of remission and exacerbation. In older patients, the disease is often accompanied by other comorbid conditions, which complicates treatment and requires a special approach to therapeutic interventions.
Questions and Answers
- What is pustular psoriasis? Pustular psoriasis is a severe form of psoriasis characterized by the formation of pustules on the skin, often accompanied by itching and pain.
- How is pustular psoriasis diagnosed? Diagnosis is based on clinical examination, laboratory tests and sometimes biopsy, which allows it to be distinguished from other skin diseases.
- What are the main risk factors for pustular psoriasis? Major risk factors include infections, stress, chronic diseases and the use of certain medications.
- How is pustular psoriasis treated? Treatment may include systemic medications, topical agents, and new biological therapies that target the immune response.
- What is the prognosis and possible complications of pustular psoriasis? The prognosis varies from long-term remissions to frequent relapses; possible complications include infections and systemic manifestations requiring medical intervention.
